CART is expressed in central nervous system (CNS) sites known to be important in the control of food intake, including the hypothalamus and hindbrain, as well as in the nodose ganglion of the vagus nerve whose central projections terminate in the nucleus tractus solitarius (NTS), an important site for peripheral feedback controlling appetite and associated motivated behaviors. Numerous groups, including ours, have demonstrated that CART inhibited food intake when administered i.c.v. in rats. In addition, others have demonstrated that central administration of antibodies to CART peptides increased feeding. These studies established the potential for endogenously produced CART peptides to be physiologically relevant regulators of food intake and overall glucose homeostasis. Those pharmacologically-based studies were corroborated by experiments using CART knockout animals and human studies which identified CART SNPs associated with metabolic dysfunction. Like other centrally-expressed anorexigenic peptides, CART exhibits functional changes in expression depending on metabolic status. In particular, CART expression is reduced in the fasted state, but returns to baseline levels upon refeeding, an effect that is conserved across multiple species. Combined, these findings suggest a critical role of CART in appetite regulation. Recently, we identified the orphan G protein-coupled receptor, GPR160, to be a cognate receptor for CART and defined the obligate role of CART signaling via GPR160 in nerve injury-induced pain sensation (PMID 31999650). Similarly, we have demonstrated the role of GPR160 in transmitting the anorexigenic action of CART (PMID 33206556) and described the localization of GPR160 on neurons and glia in hindbrain and forebrain sites known to be important in the control of ingestive behaviors including the dorsal vagal complex in the brainstem. In addition we now have established that CART administration in fourth cerebroventricle directly above the NTS exerts its anorexigenic action by not only limiting the amount of food consumed, but also by changing the patterning of the ingestive behavior. CART administration reduced the amount of food ingested per meal, the total number of food bouts, the number of food bouts per meal, and the duration of each meal, while increasing the interval between meals. Thus CART exerted significant satiation (meal bout based) and satiety (total meal amounts) effects. We have developed a transgenic rat line in which the gene for GPR160 is located within loxP sites and are examining the effects on meal patterning after compromise of receptor expression in selective brain areas, in an attempt to identify the critical sites of action of the peptide not only for the control of ingestive behaviors, but also CART's actions related to reward behavior and neuroendocrine function.
Read full abstract